ClinConnect ClinConnect Logo
Search / Trial NCT02138266

Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements

Launched by TOPCON MEDICAL SYSTEMS, INC. · May 12, 2014

Trial Information

Current as of July 21, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria -Non-Pathologic Young Adults (18-28 years old) and Non-Pathologic Adults (29-80 years old):
  • Male or female subjects from 18 to 80 years old who have full legal capacity to volunteer on the date the informed consent is signed;
  • Subjects who can follow the instructions by the clinical staff at the clinical site, and can attend examinations on the scheduled examination date;
  • Subjects who agree to participate in the study.
  • Inclusion Criteria -Pathologic Adults (29-80 years old)
  • Male and female subjects from 29 to 80 years old who have full legal capacity to volunteer on the date the informed consent is signed;
  • Subjects who can follow the instructions by the clinical staff at the clinical site, and can attend examinations on the scheduled examination date;
  • Subjects who agree to participate in the study;
  • * At least one eye with any of the following conditions:
  • History of post-op surgical trauma including Pseudophakic or Aphakic bullous keratopathy;
  • History of corneal transplant;
  • Physical injury or trauma to the cornea;
  • Long term Fuch's dystrophy/Guttata (and other corneal endothelial dystrophies)
  • Keratoconus;
  • Long term PMMA contact lens use (greater than 3 years).
  • Exclusion Criteria -Non-Pathologic Young Adults (18-28 years old) and Non Pathologic Adults (29-80 years old)
  • History of corneal transplant;
  • Long term Fuch's dystrophy (and other corneal endothelial dystrophies);
  • Keratoconus;
  • Guttata;
  • Diabetes mellitus type I or type II;
  • History of cataract, refractive or ocular surgical procedures that render the cornea opaque or otherwise impact its ability to be imaged using the investigational device;
  • All contact lens wearers;
  • Fixation problems which may prevent obtaining good quality SP-1P and CELLCHEK PLUS in either eye.
  • Exclusion Criteria -Pathologic Adults (29-80 years old):
  • Fixation problems which may prevent obtaining at least poor quality (refer to Figure 1) SP-1P and KONAN CELLCHEK PLUS images in either eye.

About Topcon Medical Systems, Inc.

Topcon Medical Systems, Inc. is a leading provider of advanced ophthalmic equipment and technology, dedicated to enhancing the diagnosis and treatment of eye care conditions. With a commitment to innovation and quality, Topcon develops a comprehensive range of diagnostic instruments and software solutions that empower eye care professionals to deliver superior patient care. The company actively engages in clinical trials to advance the field of ophthalmology, ensuring that their products meet the highest standards of efficacy and safety. Through collaboration with healthcare providers and researchers, Topcon aims to improve patient outcomes and drive advancements in vision science.

Locations

Andover, Massachusetts, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials